IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies

por Parrondo, Ricardo D., Iqbal, Madiha, Von Roemeling, Reinhard, Von Roemeling, Christina, Tun, Han W.
Publicado 2023

Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery

por Chen, Yuanxin, Liu, Xiujie, Yuan, Hengfeng, Yang, Zhaogang, von Roemeling, Christina A., Qie, Yaqing, Zhao, Hai, Wang, Yifan, Jiang, Wen, Kim, Betty Y. S.
Publicado 2019

Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma

por Yushi, Qiu, Li, Zhimin, Von Roemeling, Christina A., Doeppler, Heike, Marlow, Laura A., Kim, Betty Y.S., Radisky, Derek C., Storz, Peter, Copland, John A., Tun, Han W.
Publicado 2016

Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma

por Tun, Han W., Marlow, Laura A., von Roemeling, Christina A., Cooper, Simon J., Kreinest, Pamela, Wu, Kevin, Luxon, Bruce A., Sinha, Mala, Anastasiadis, Panos Z., Copland, John A.
Publicado 2010

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

por Qie, Yaqing, Yuan, Hengfeng, von Roemeling, Christina A., Chen, Yuanxin, Liu, Xiujie, Shih, Kevin D., Knight, Joshua A., Tun, Han W., Wharen, Robert E., Jiang, Wen, Kim, Betty Y.S.
Publicado 2016

Corrigendum: Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

por Qie, Yaqing, Yuan, Hengfeng, von Roemeling, Christina A., Chen, Yuanxin, Liu, Xiujie, Shih, Kevin D., Knight, Joshua A., Tun, Han W., Wharen, Robert E., Jiang, Wen, Kim, Betty Y. S.
Publicado 2016

An Effective Personalized Approach to a Rare Tumor: Prolonged Survival in Metastatic Pancreatic Acinar Cell Carcinoma Based on Genetic Analysis and Cell Line Development

por Armstrong, Matthew D., Von Hoff, Daniel, Barber, Bruce, Marlow, Laura A., von Roemeling, Christina, Cooper, Simon J., Travis, Patrick, Campbell, Elizabeth, Paz-Fumagalli, Ricardo, Copland, John A., Colon-Otero, Gerardo
Publicado 2011

Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases

por Von Roemeling, Christina A., Doonan, Bently P., Klippel, Kelena, Schultz, Daniel, Hoang-Minh, Lan, Trivedi, Vrunda, Li, Chenglong, Russell, Rylynn A., Kanumuri, Raju S., Sharma, Abhisheak, Tun, Han W., Mitchell, Duane A.
Publicado 2023

Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration

por von Roemeling, Christina A., Marlow, Laura A., Radisky, Derek C., Rohl, Austin, Larsen, Hege E., Wei, Johnny, Sasinowska, Heather, Zhu, Heng, Drake, Richard, Sasinowski, Maciek, Tun, Han W., Copland, John A.
Publicado 2014

Investigation and modulation of interleukin-6 following subarachnoid hemorrhage: targeting inflammatory activation for cerebral vasospasm

por Lucke-Wold, Brandon, Dodd, William, Motwani, Kartik, Hosaka, Koji, Laurent, Dimitri, Martinez, Melanie, Dugan, Victoria, Chalouhi, Nohra, Lucke-Wold, Noelle, Barpujari, Arnav, von Roemeling, Christina, Li, Chenglong, Johnson, Richard D., Hoh, Brian
Publicado 2022

CXCL9 recombinant adeno-associated virus (AAV) virotherapy sensitizes glioblastoma (GBM) to anti-PD-1 immune checkpoint blockade

por von Roemeling, Christina, Yegorov, Oleg, Yang, Changlin, Klippel, Kelena, Russell, Rylynn, Trivedi, Vrunda, Bhatia, Alisha, Doonan, Bently, Carpenter, Savannah, Ryu, Daniel, Grippen, Adam, Futch, Hunter, Ran, Yong, Hoang-Minh, Lan, Weidert, Frances, Golde, Todd, Mitchell, Duane
Publicado 2023

Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy

por von Roemeling, Christina A., Caulfield, Thomas R., Marlow, Laura, Bok, Ilah, Wen, Jiang, Miller, James L., Hughes, Robert, Hazlehurst, Lori, Pinkerton, Anthony B., Radisky, Derek C., Tun, Han W., Kim, Yon Son Betty, Lane, Amy L., Copland, John A.
Publicado 2017

IMMU-06. SYSTEMIC MRNA VACCINES RESET IMMUNOGENICITY AGAINST DIFFUSE MIDLINE GLIOMA

por McGuiness, James, Weidert, Frances, DeVries, Anna, Ligon, John, Zhang, Dingpeng, Von Roemeling, Christina, Grippin, Adam, Karachi, Aida, Qdaisat, Sadeem, Thomas, Nagheme, Castillo, Paul, Huang, Jianping, Silver, Natalie, Rahman, Maryam, Hwang, Eugene, Mitchell, Duane, Mendez-Gomez, Hector, Sayour, Elias
Publicado 2023

Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity

por von Roemeling, Christina A., Wang, Yifan, Qie, Yaqing, Yuan, Hengfeng, Zhao, Hai, Liu, Xiujie, Yang, Zhaogang, Yang, Mingming, Deng, Weiye, Bruno, Katelyn A., Chan, Charles K., Lee, Andrew S., Rosenfeld, Stephen S., Yun, Kyuson, Johnson, Aaron J., Mitchell, Duane A., Jiang, Wen, Kim, Betty Y. S.
Publicado 2020